论文部分内容阅读
为探讨Ｇｒａｖｅｓ病抗甲状腺药物不同治疗方法及其治疗效果，我们对１０４例Ｇｒａｖｅｓ病患者分组进行了治疗观察。Ａ组单用抗甲状腺药物治疗，当血清Ｔ３、Ｔ４降至正常水平，逐渐减药并维持治疗，疗程１５年。Ｂ组抗甲状腺药物与甲状腺片同时服用，当患者血清Ｔ３、Ｔ４降至正常水平，逐渐减抗甲状腺药物并维持治疗，疗程１５年。Ｃ组所服药物及剂量同Ｂ组，当血清Ｔ３、Ｔ４降至正常水平，逐渐减抗甲状腺药物并维持治疗，疗程２５年。结果表明，疗程结束１年后复查时，Ａ、Ｂ两组甲亢复发例数及血清Ｔ３、Ｔ４水平明显高于Ｃ组。提示Ｃ组Ｇｒａｖｅｓ病患者治疗方法及疗效较好
To investigate the different therapies and therapies for anti-thyroid drugs in Graves disease, 104 patients with Graves disease were treated. A group with anti-thyroid drugs alone, when the serum T3, T4 dropped to normal levels, and gradually reduce the treatment and maintenance of treatment for 1.5 years. Group B anti-thyroid drugs and thyroid tablets taken at the same time, when the patient serum T3, T4 dropped to normal levels, and gradually reduce the thyroid drugs and maintenance of treatment, treatment of 1.5 years. C group taking the drug and dose with the B group, when the serum T3, T4 dropped to normal levels, gradual reduction of thyroid drugs and maintenance therapy, treatment of 2 5 years. The results showed that the number of recurrent hyperthyroidism and serum T3, T4 levels in A and B groups were significantly higher than those in C group after 1 year after the end of treatment. Tip C group Graves disease treatment and efficacy is better